Combination therapy

Details for Australian Patent Application No. 2006212761 (hide)

Owner Xenon Pharmaceuticals Inc.

Inventors Fu, Jian-Min; Winther, Michael; Sun, Sengen; Seid Bagherzadeh, Mehran; Raina, Vandna; Kamboj, Rajender; Fraser, Robert; Hou, Duanjie; Kondratenko, Mikhail; Abreo, Melwyn; Chafeev, Mikhail; Hudson, Cindy; Tu, Chi; Holladay, Mark; Li, Wenbao; Gschwend, Heinz; Sadalapure, Kashinath; Liu, Shifeng; Harvey, Daniel

Agent Davies Collison Cave

Pub. Number AU-B-2006212761

PCT Pub. Number WO2006/086445

Priority 60/651,584 09.02.05 US

Filing date 8 February 2006

Wipo publication date 17 August 2006

Acceptance publication date 2 July 2009

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/086445 Priority application(s): WO2006/086445

2 July 2009 Application Accepted

  Published as AU-B-2006212761

29 October 2009 Standard Patent Sealed

1 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006212763-Pyridazine derivatives and their use as therapeutic agents

2006212754-Compositions and methods for detecting Group B Streptococci